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Summary We are conducting a long-term randomized controlled trial to determine if intervention with a low-fat high-carbohydrate diet
reduces breast cancer risk. The present study examines the effects of 2 years of dietary intervention on serum sex hormone levels in
premenopausal women. Subjects with extensive mammographic densities were enrolled in a dietary intervention trial. The intervention
involved intensive individual counselling aimed at reducing total dietary fat to 15% of calories. Control subjects received general advice about
diet but were not counselled to change their fat intake. Serum sex hormone levels were measured in 220 premenopausal subjects at entry
and 2 years after randomization. Two years after randomization oestradiol levels were 20% (70 pmol 1-1) lower (P = 0.04) and progesterone
levels were 35% (1.0 nmol 1-1) lower (P = 0.004) and follicle-stimulating hormone (FSH) levels were 7% (1 IU) higher (P = 0.38) in the
intervention group than in the control group. The FSH-oestradiol ratio was 13% higher in the intervention group (P= 0.18). Samples analysed
accounting for the timing of the blood sample in relation to the menstrual cycle showed that, in the intervention group, oestradiol and
progesterone levels were lower and FSH levels higher in subjects with blood samples taken more than 30 days afterthe last menstrual period.
Because of the strong evidence linking ovarian hormonal activity to breast cancer risk, these results suggest that a low-fat high-carbohydrate
diet may reduce risk of breast cancer by reducing exposure to ovarian hormones that are a stimulus to cell division in the breast.
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Risk ofbreast cancer is modified by several factors, including age
at menarche, age at menopause and age at first live birth. Some of
these risk factors suggest an important role for ovarian hormones
in the development of the disease. The importance of ovarian
hormones is confirmed by the observation that oophorectomy in
premenopausal women reduces risk ofbreast cancer, riskreduction
being greater the earlier in life it is carried out (Kelsey et al, 1993).
Also, age-specific incidence rates of breast cancer vary widely
around the world, and are about five times higher in northern
Europe and North America than in Asia (International Agency for
Research on Cancer, 1992). This variation cannot be explained by
inherited differences between populations, because migrants from
low-risk to high-risk countries show a marked increase in risk.
Further, the children of migrants eventually acquire the incidence
of the country to which they have moved (McMichael, 1988;
Kelsey and Horn-Ross, 1993). Human ecological studies show
that breast cancer incidence and mortality are strongly and posi-
tively correlated with estimates of dietary fat consumption within
countries (r = 0.8-0.9) (Prentice et al, 1988). Although dietary fat
intake influences breast cancer risk in animals (see Rogers and
Lee, 1986; Freedman et al, 1990; Welsch, 1992 for reviews),
observational cohort and case-control studies have either failed to
show any associations between fat intake and risk ofbreast cancer
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or have shown only weak associations (see Goodwin and Boyd,
1987; Howe et al, 1990; Willett et al, 1992; Boyd etal, 1993). This
difference in the findings of ecological and observational studies
may indicate a true lack of association between dietary fat and
breast cancer, or may arise because the range of intakes within
countries is much smaller than between countries.
To examine the effects on breast cancer incidence of a wider
range of dietary fat intake, we are carrying out a long-term
randomized controlled trial designed to determine if intervention
with a low-fat high-carbohydrate dietreduces riskofbreast cancer.
The purpose ofthe present study is to examine the early effects of
this dietary intervention on serum sex hormones in premenopausal
women taking part in this trial.
METHODS
General method
The present study was carried out within a larger multicentre
randomized controlled trial designed to determine whether, given
optimal circumstances, the incidence of breast cancer in a high-
risk population can be reduced by an intervention involving a
reduction in dietary fat intake and an increase in intake ofcomplex
carbohydrate.
We recruited subjects with mammographic densities in at least
50% of the breast area, a risk factor for breast cancer (Oza and
Boyd, 1993), and enrolled them in a randomized trial of dietary
intervention aimed at reducing total dietary fat to a target of 15%
ofcalories. Control subjects received general advice about diet but
were not counselled to change their intake offat. Enrolled subjects
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were aged between 30 and 65 years, and lived within easy
commuting distance ofthe participating centre.
The centres from which participants were drawn are located
in Toronto, Hamilton, London and Windsor (Ontario) and in
Vancouver (British Columbia). Subjects were excluded ifthey had
a previous history of cancer or breast augmentation or reduction,
were pregnant (or planning to be) or breast feeding, or were on a
medically prescribed diet for any reason. Eligible subjects were
initially contacted by letter followed by a telephone call from
study staff. Interested and eligible subjects were given an appoint-
ment with a study dietitian, to confirm eligibility and assess the
suitability of subjects for the trial. Before randomization, subjects
were asked to keep dietary records for three non-consecutive
randomly selected days and to keep two clinic appointments.
Subjects who kept satisfactory records of dietary intake and who
have written consent to enter the study, were randomized by tele-
phone contact with the Department of Biostatistics at the Ontario
Cancer Institute. Randomization was stratified according to centre
and balanced within each centre. The present study is concemed
only with the effects ofthis intervention on blood levels ofoestra-
diol, progesterone and follicle-simulating hormone (FSH) in pre-
menopausal subjects, and is limited to subjects enrolled in trial
sites in Ontario.
Dietary intervention
For subjects randomized to the intervention group of the trial, an
isocaloric diet was calculated based upon 15% of calories derived
from fat, 20% from protein and 65% from carbohydrate. A dietary
prescription was prepared for each subject, using a food exchange
system in which calories derived from fat were replaced by
isocaloric exchange with carbohydrate. Subjects were also given
dietary aids including dietetic scales, and a printed guide (The Fat
Factor) containing low-fat recipes, a low-fat shopping guide and
the individual's diet prescription. No attempt was made in the
intervention to change intake ofalcohol.
Follow-up
After randomization, subjects in the intervention group visited the
dietitian once a month for the first 12 months; subjects in the
control group once every 3 months. Both groups were seen once
every 3 months for the second year. At each of these visits,
subjects were asked to provide a record of 3 days of food
consumption. Food records were kept on non-consecutive days in
the interval before the next clinic visit, and included two weekdays
and one weekend day, chosen by the dietitian. Nutrient analysis of
food records was performed using the Minnesota Nutrient Data
System (NDS) software, developed by the Nutrition Coordinating
Center (NCC), University of Minnesota, Minneapolis, MN, USA.
Thirteen per cent ofpremenopausal subjects dropped out before 2
years: 9% of control subjects and 17% of the intervention group.
The most frequently cited reasons for dropping out were lack of
time for the study or finding the dietary intervention too difficult.
Blood collection
Blood was taken by venepuncture from subjects at entry to the trial
and once a year after that. Blood was taken at the time of clinic
visits and not timed in relation to the menstrual cycle. The date of
the last menstrual period was recorded at the first interview and at
2 years. However, because the assessment ofsubjects before entry
to the trial sometimes lasted several weeks, the date of the last
period at interview was often far removed from the date of blood
collection at baseline. Hence, the day of the last period could not
be used to analyse the results of blood taken at baseline. Blood
taken at 2 years, however, was drawn on the day ofinterview, and
the date ofthe last menstrual period could therefore be used in the
analysis. Serum was separated atthe time ofcollection and divided
into 2-ml aliquots and stored at-70°C.
Hormone assays
Progesterone, oestradiol, and FSH were assayed by radioim-
munoassay in the Steroid Hormone laboratory, Wellesley Hospital,
Toronto, the steroid hormone laboratory for the University of
Toronto teaching hospitals. All hormone assay kits were from
Diagnostic Products Corporation. Oestradiol and FSH were both
double-antibody assays and progesterone a solid-phase assay. The
quality control procedures included duplicate assays and three
control samples with known high, intermediate and low values.
Assays were performed on batches containing equal numbers of
blood samples from intervention and control groups. The
interassay coefficients of variation for high, intermediate and low
values were, respectively, 7.8%, 7.9% and 7.1% foroestradiol, 6%,
9% and 12% for progesterone and 5.8%, 4.5% and 6.3% for FSH.
Selection of subjects for the present study
The 216 subjects whose data are analysed in the present paper
were selected from a total of 240 subjects (122 intervention and
118 control subjects) who were premenopausal, not taking exoge-
nous hormones at the time of randomization and remained in the
study at 2 years. Ofthese 240, 24 (ten intervention and 14 control
subjects) were excluded from analysis for the following reasons:
14 spontaneously became post-menopausal before 2 years (eight
Table 1 Selected baseline demographic characteristics of subjects
Characteristics Intervention Control P-value
No. of subjects 112 104
Age 42.8 ± 4.8a 42.2 ± 4.7 0.37b
Age (%)
< 35 4.5 3.8 0.80c
35-39 9.8 13.5
40-44 34.8 39.4
45-49 33.0 27.9
> 50 17.9 15.4
Marital status (%)
Never married 20 20 0.92c
Ever married 80 80
Weight (kg) 61.0± 7.7 61.1 ± 9.1 0.95b
Height (cm) 163.1 ± 5.4 162.8 ± 5.8 0.68b
Age at menarche 12.7 ± 1.5 12.9 ± 1.4 0.18b
Parity (% parous) 68 63 0.41c
Age at first live birth 25.2 ± 4.9 26.4 ± 4.9 0.15b
First-degree relative with
breast cancer (%) 24 14 0.08c
aMean ± standard deviation; bt-test; cchi-square.
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intervention and six controls subjects), and a further four members
of the control group had hysterectomies with removal of the
ovaries; five started exogenous hormones (two intervention and
three control subjects); and one control subject had missing infor-
mation about hormone use. Included in the 216 subjects were 19
women (eight intervention and 11 control subjects) who had
hysterectomies without the removal ofboth ovaries.
Statistical methods
Subject characteristics were compared between the intervention
and control groups using chi-square and t-tests. The distributions
of the hormone levels were highly skewed, and no transformation
successfully corrected this problem for both time points, therefore
the hormone levels at baseline and 2 years were compared between
the groups using Wilcoxon rank-sum tests. To allow adjustment
for any baseline differences between the groups, we also examined
changes in hormone levels. The changes in hormone levels were
calculated by subtracting the baseline value from the 2-year value
and were compared between intervention and control groups using
the Wilcoxon rank-sum test because of non-normality. These
analyses were repeated excluding the 19 subjects who had
hysterectomies without the removal ofboth ovaries.
The 2-year data were also examined accounting for the day
since the last menstrual period on which the sample of blood was
taken using two approaches. Subjects who had had a hysterectomy
were excluded from these analyses. In the first approach, hormone
levels at 2 years were analysed according to both the day of the
cycle on which blood was drawn (< 15 days, 16-30 days, > 30
days) and the serum progesterone level in the sample (< 5 nmol 1-';
> 5 nmol L-l). Wilcoxon tests were used to compare intervention
and control groups within each subgroup.
In the second approach, we examined log-transformed hormone
levels at 2 years, which were acceptably normal, using modelling
procedures to test for group differences while controlling for age,
weight at 2 years and day ofmenstrual cycle that the blood sample
was taken, and to look for possible interactions between group
membership and interval between last menstrual period and day of
blood sample. The relationship between hormone level and day of
blood sample is not linear and must be modelled as a non-linear
term. Generalized additive models provide one way to extend the
linear model (Hastie and Tibshirani, 1990). Non-linear terms can
be incorporated into the model by representing them as data-
defined non-parametric smooth functions, thus avoiding the need
to identify the correct parametric transformation for each variable.
If we consider a model for a random response variable Y, and a
set of random predictor variables, Xl, X2,..., Xp, a standard linear
regression model takes the form:
E(Y Xil,...,9Xp)= 10+P, Xl +... + pXp,
The additive model generalizes the linear regression model as
follows:
E(Y XI ... X)=so +X sj.(X),
where the sj (.)s are smooth, possibly non-linear, functions. In
the models we have considered here we have only one non-linear
term (day of blood sample), so our model has a mixture of linear
terms (age and weight) with one non-linear term. To estimate the
non-linear term we have used running least square lines (LOESS)
(Hastie, 1992).
Table 2 Intake of selected nutrients as assessed by food records according to group and time of data collection
Time
Baseline (I = 112/C = 104) Two years (I = 104/C = 100)
Nutrient Group Mean s.d. Mean s.d.
Energy (kcal day-') 1660.0 402.5 1540.4 317.1
C 1697.6 445.1 1758.9 436.6
Total fat (% of energy) 34.0 6.3 21.2 6.0
C 34.3 5.8 33.1 6.7
Saturated fats (% of energy) 12.4 3.0 7.2 2.5
C 12.3 3.4 12.3 3.4
Polyunsaturated fats (% of energy) 6.6 2.1 4.4 1.7
C 6.9 2.0 6.4 2.1
Monounsaturated fats (% of energy) 12.3 2.9 7.5 2.6
C 12.5 2.4 11.7 2.7
Protein (% of energy) 16.7 3.5 18.0 3.2
C 17.0 3.6 16.9 2.8
Total carbohydrates (% of energy) 48.0 7.4 60.3 8.3
C 47.3 7.5 48.8 8.1
Total fibre (g day-') 16.1 5.3 18.8 5.6
C 16.2 6.8 17.5 7.6
Weight (kg) 60.8 7.6 60.8 7.6
C 60.8 9.2 62.1 9.8
Standard deviation.
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Table 3 Median hormone levels and changes according to group and time of data collection
Hormone Intervention (n = 112) Control (n = 104) PLvaluea
Oestradiol (pmol 1-')
Baseline 290.5 (187, 480)b 313.5 (177, 469) 0.90
Two years 275 (123,451) 345 (185,455) 0.04
Change at 2 yearsc -40.5 (-188,183) 9 (-166,193) 0.35
Progesterone (nmol 1-')
Baseline 3.3 (1.6,17) 4.2 (1.9, 29.5) 0.17
Two years 2.0 (1.1, 5.9) 3.0 (1.5, 22) 0.005
Change at 2 years -0.9 (-9.0, 1.8) -0.6 (-9.0, 4.5) 0.77
FSH (IU)d
Baseline 13.0 (9.5,17) 11.0 (7,17) 0.08
Two years 15.0 (9, 33) 14.0 (9, 24) 0.39
Change at 2 years 1.0 (-0.4,14) 2.0 (-0.3, 8) 0.53
FSH/E2e
Baseline 0.045 (0.023, 0.103) 0.038 (0.020,0.076) 0.35
Two years 0.058 (0.023, 0.212) 0.053 (0.022, 0.109) 0.18
Change at 2 years 0.010 (-0.033, 0.126) 0.006 (-0.035, 0.056) 0.23
aWilcoxon two-sample test; bmedian (first quartile, third quartile); ctwo-year level-baseline level; dFSH, follicule-stimulating
hormone; eratio of FSH to oestradiol.
Table 4 Median serum hormone levels according to day of blood collection and serum progesterone level
Intervention Control
Progesterone Progesterone Progesterone Progesterone
Dayofcycle <5 >5 All <5 >5 All
Oestradiol
1-15 230 (121,477)a 498.5 (307,626)b 270 (124,545) 223 (137,436) 318 (219,359) 267 (149,424)
16-30 313 (198,328) 307 (220,457) 310 (209,454) 214.5 (83.5,444.5) 381 (286.5,473.5) 371 (228.5,452.5)
> 30 46 (37,84)c 292 (249,235) 61 (41,114)d 441 (244,506) 402 (317,422) 412 (245,452)
Progesterone
1-15 1.6 (0.9,2.1) 18.5 (9,31) 1.8 (1,2.7) 1.4 (1.1,2.2) 17.5 (10,27) 1.6 (1.2,3)
16-30 1.2 (1.1,2.8) 26.1 (17,42) 17.5 (2.85,30.5) 2.15 (1.7,3.65) 30 (16,48) 18 (4.3,37)
> 30 1.4 (0.8,1.9) 20.95 (7.9,34) 1.5 (1.2,3)b 2.4 (1,2.6) 24 (23,41) 12.4 (2.4,24)
FSH
1-15 14 (11,22) 17 (9,25) 14 (10,22) 14 (12,17) 19.5 (12,42) 15 (12,21)
16-30 20 (16,39) 8 (7,9) 9 (7,16) 12 (9,42.5) 9 (6.5,13) 10 (7,14.5)
> 30 96 (69,158)e 17.5 (6,29) 86 (58,153)c 48 (46,48) 10 (9,13) 19 (10,48)
FSH/Oestradiol
1-15 0.08 (0.02,0.16) 0.05 (0.01,0.06) 0.07 (0.02,0.16) 0.07 (0.02,0.16) 0.09 (0.03,0.11) 0.07 (0.02,0.13)
16-30 0.07 (0.05,0.17) 0.02 (0.02,0.04) 0.03 (0.02,0.06) 0.08 (0.05,0.10) 0.02 (0.02,0.04) 0.03 (0.02,0.06)
> 30 2.42 (1.02,4.14)e 0.06 (0.02,0.09) 1.30 (0.93,3.22)c 0.14 (0.09,0.19) 0.03 (0.02,0.03) 0.04 (0.02,0.14)
Number
1-15 49 6 55 35 6 41
16-30 9 19 28 12 28 40
> 30 11 2 13 5 5 10
aMedian (first quartile, third quartile); Wilcoxon tests compare intervention and control groups overall and within each of the categories of progesterone levels;
bo.05 < P< 0.1;cQ.001 < P< 0.01 dp< 0.001; e0.01 < P< 0.05
RESULTS
Characteristics of subjects
Table 1 shows selected baseline characteristics of the subjects
included in the present study. There were 112 subjects in the inter-
vention group and 104control subjects. The mean age atrandomiza-
tion was 42-43 years. Subjects in intervention and control groups
were similar at the time of randomization in terms of age
distribution, height, weight and other risk factors for breast cancer.
Twenty-four per cent of the intervention group and 14% of control
subjects reported at least onefirst-degree relative withbreast cancer.
Dietary characteristics
Table 2 shows the intake of selected nutrients as estimated from
food records. The values shown are mean intakes calculated from
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food records collected at baseline and at 2 years. Food records at 2
years were missing foreight subjects in the intervention group and
for four control subjects. Nutrient analysis offood records at base-
line showed that the nutrient intake of control and intervention
groups were similar. Two years after randomization, the mean
total energy intake of the intervention group was approximately
122 kcal per day less than at baseline. The mean percentage of
energy derived from fat fell from 34% to 21% in the intervention
group as the result of a reduction in intake of saturated, monoun-
saturated and polyunsaturated fat, but was unchanged from base-
line in control subjects.
Total carbohydrate intake rose from 48% to 60% of energy in
the intervention group, and intake of total dietary fibre increased
from 16 to 19 g day-'. All ofthe differences between intervention
and control groups in the intake of fat, type of fat, carbohydrate
and fibre were statistically significant (P < 0.001).
Body weight was unchanged at 2 years in the intervention group
and in the control group increased by 1.3 kg.
Analysis of hormone levels and 2-year changes
The medians for hormone levels at baseline and 2 years and the
median individual changes at 2 years are shown in Table 3.
Because the changes in levels are calculated for individuals before
A
Intervention group
the median change is determined, the change in level is not the
same as the difference between the group median values at base-
line and 2 years. In the intervention group the median change in
oestradiol was a 13.9% (40 pmol 1-1) reduction over 2 years
compared with a 2.9% increase (9 pmol 1-') in the control group.
The level was 20.3% lower in the intervention group than the
control group at 2 years (P = 0.04). The progesterone level was
33% lower in the intervention than the control group at 2 years
(P = 0.005). Differences between groups in FSH levels were not
statistically significant at 2 years (P = 0.39). The median change in
the ratio of FSH to oestradiol was an increase of 22.2% in the
intervention group compared with an increase of 15.8% in the
control group. The ratio at 2 years was not significantly different
between the intervention and the control group (P = 0.18).
In contrast to the hormone level comparisons for oestradiol and
progesterone, the median individual changes from baseline to 2
years were not statistically significant between groups. At least for
oestradiol, which shows a large decrease in the intervention group,
despite having a lower baseline value than the control subjects, this
may be accounted for in part by the increased variation in the
change variable, whichhampers the power ofthe test fordifferences
Hormone levels and changes were also analysed excluding the
subjects who had a hysterectomy without the removal of an ovary.
The results were similar and are not shown here.
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Analysis of 2-year hormone levels according to day
since last menstrual period
One hundred and eighty-nine subjects had a recorded date of last
menstrual period at their 2-year visit. The blood sample was taken
a median of 24 days after the last period in the intervention group
and 22 days after in the control group (Wilcoxon test: P = 0.12).
Table 4 examines the effects of the day of the menstrual cycle
on which blood was taken, and of ovulation, on the 2-year
hormone levels. Subjects are divided into three groups according
to the day of sampling (1-15, 16-30 and > 30 days) and further
according to the progesterone value on the day of sampling
(< 5 nmol 1-1 and > 5 nmol 1-1). The median values, and 25% and
75% values ofhormone assays for intervention and control groups
divided in this way are shown in the table.
For all subjects, before taking progesterone level into account,
as well as after partitioning subjects according to progesterone
level when blood was drawn less than 30 days after the last
menstrual period, levels of oestradiol, progesterone, FSH and the
ratio ofFSH to oestradiol were similar in intervention and control
groups. An exception was the oestradiol value for intervention
subjects with progesterone value more than 5 nmol 1-', and blood
taken 1-15 days after the last period, which was higher in the
intervention group than in control subjects and of borderline
significance (0.05 < P < 0.10).
Differences between intervention and control groups were
found for hormones assayed in bloods taken more than 30 days
since the last menstrual period. For all subjects, before taking into
account progesterone level, oestradiol levels were seven times
higher (P < 0.001) and progesterone levels eight times higher
(0.05 < P < 0.10) in control than in intervention subjects. FSH
levels were 4.5 times higher (0.001 < P < 0.01) and the ratio of
FSH to oestradiol was 32 times higher (0.001 < P < 0.01) in inter-
vention subjects than in control subjects. Within each of the two
categories of progesterone level, oestradiol and progesterone
levels were lower in the intervention group than in control
subjects, and FSH and the ratio ofFSH to oestradiol was higher in
the intervention group than in control subjects. For oestradiol,
FSH and the ratio of FSH to oestradiol, these differences were
statistically significant only for subjects with progesterone levels
less than 5 nmol 1-'. It is notable that all of these differences found
between intervention and control group are seen in the same time
interval after the last menstrual period, and that the lower level of
oestradiol is associated with the expected higher level of FSH.
Chance is therefore unlikely to explain these findings.
To look for interaction effects between group membership and
the timing of the blood sampling on hormone levels, we also
examined log-transformed hormone levels between intervention
and control groups at 2 years, controlling for weight at 2 years, age
and length of time between the blood sample date and date of the
start ofthe last menstrual period.
Oestradiol levels were not significantly affected by either
weight (P = 0.60) or age (P = 0.26). Oestradiol levels were,
however, significantly affected by a strong interaction between
group membership and timing of the blood sample (P = 0.008).
This interaction shows that the relationship between oestradiol
level and the day the sample was taken was statistically signifi-
cantly different for the intervention and control groups. The inter-
action is illustrated in Figure IA. The top panel shows that, for the
intervention group, oestradiol fell with increasing time between
the last menstrual period and the day ofblood sample, whereas in
the control group (bottom panel) oestradiol remained at about the
same level over the range ofday of blood sample. Figure 1A also
shows that more subjects in the intervention group were sampled
at long intervals after their last period than in the control group,
suggesting that more subjects in the intervention group were
becoming perimenopausal.
No statistically significant interactions were found between
group membership and the day of sampling on levels of proges-
terone or FSH (Figure lB and C). However, levels ofprogesterone
were significantly influenced by age (P = 0.001) and day of the
blood sample (P << 0.0001), but not by weight (P = 0.26), and
FSH levels were significantly influenced by age (P << 0.0001) and
day ofblood sample (P << 0.0001), but not by weight (P = 0.10).
Group did not have a significant effect for either of these
hormones (P = 0.10 and P = 0.76 respectively).
The ratio of FSH to oestradiol was significantly related to
weight (P = 0.03) and age (P = 0.0001). In addition, as for oestra-
diol, there was a significant association between the ratio of FSH
to oestradiol and the interaction of group membership and timing
ofthe blood sample (P < 0.0001) (Figure ID), with a ratio ofFSH
to oestradiol much higher for later blood samples in the interven-
tion group than in control subjects.
DISCUSSION
These results show that, after 2 years on a low-fat high-carbo-
hydrate diet, serum oestradiol levels were 20.3% lower among
premenopausal members of the intervention group in a random-
ized controlled trial of dietary intervention. The effect of the
intervention on oestradiol levels is seen both before and after
controlling for the day ofthe menstrual cycle on which blood was
collected, and confirmed by finding a statistically significant inter-
action between oestradiol level, dietary group and the day ofblood
collection. The observed effects of group assignment in the trial
were independent ofthe influence ofage and weight. The effect of
dietary intervention on oestradiol levels appears to be due to
longer menstrual cycles in a relatively small number ofsubjects in
the intervention group, and this result should, therefore, be repli-
cated in a larger number of subjects. However, blood levels of
oestradiol are known to fall in the years that precede the
menopause (Sherman et al, 1976), and an acceleration of these
changes might explain the reduction in oestradiol levels and the
long intervals between last menstrual period and the day of blood
sampling observed in premenopausal women in the present study.
The effects of the dietary intervention on progesterone and FSH
levels are also suggested by these data but, in the absence of
significant interaction terms, require further investigation. These
results suggestthat one mechanismby which a low-fathigh-carbo-
hydrate diet might reduce risk of breast cancer is by reducing
exposure of breast tissue to ovarian hormones that are a stimulus
to cell division in the breast.
Oestrogens can induce and promote mammary tumours in
rodents, and the administration ofan antioestrogenic drug protects
against this effect (Dao, 1981). There is much indirect evidence
that oestrogens influence breast cancer risk in humans, including
the 100-fold excess of the disease in women relative to men, the
role that early menarche and late menopause have as factors that
increase risk of the disease, as well as the effect that early age at
first birth and parity have in reducing risk of breast cancer (Key
andPike, 1988; Bernstein and Ross, 1993). Removal ofthe ovaries
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in premenopausal women decreases the risk of breast cancer, and
risk reduction is greater the earlier in life oophorectomy is
performed.
Further, populations at low risk for breast cancer have repeat-
edly been shown to have low blood levels of oestrogen relative to
populations at high risk for the disease. This difference in levels of
oestrogens has been found in both pre- and post-menopausal
women. For example, British women aged 35-44, have been
found to have oestradiol concentrations 36% higher on average
than those of Chinese women of the same age (Key et al, 1990).
Comparisons of premenopausal Western women with Asian
women living in Japan (MacMahon et al, 1974; Hayward et al,
1978; Gray et al, 1982) or China (Bernstein et al, 1990), or recent
migrants to Hawaii (Goldin et al, 1986), have also, in general,
found lower oestrogen levels in the group of women at lower risk
ofbreast cancer. In post-menopausal women it has been found that
American whites have oestradiol levels three times those ofrecent
Asian migrants to Hawaii (Goldin et al, 1986). Similar results have
been found in a comparison of rural Japanese women and white
women living in southern California (Shimizu et al, 1990). These
observations are consistent with the hypothesis that oestrogens
play an important role in the aetiology of breast cancer.
Case-control and cohort studies provide some further support for
this hypothesis, although the data are most consistent for post-
menopausal women (Key and Pike, 1988; Toniolo et al, 1995).
These international comparisons provide indirect evidence that
dietary differences are associated with different levels of plasma
sex hormones. All involve comparisons of populations with
substantially different diets, and populations with lower breast
cancer risk also in general have a lower intake of dietary fat and
lower plasma oestrogen levels. Further, significantly higher levels
of sex hormone-binding globulin, lower plasma levels of oestra-
diol and lower urinary oestrogen excretion have been found in
vegetarians than in non-vegetarians (Armstrong et al, 1981;
Goldin et al, 1982).
Experimental evidence showing a relationship between change
in diet and change in sex hormone levels is available from several
studies (Rose et al, 1987; 1991; Woods et al, 1989; Prentice et al,
1990). These studies have, however, generally involved small
numbers of subjects, have not included concurrent control groups
and, without exception, have been of short duration. They show,
however, that the adoption of a low-fat diet is associated with a
significant reduction ofblood oestrogen concentrations in pre- and
post-menopausal women.
Although the present results suggest that diet is casually related
to serum oestradiol levels, epidemiological evidence on the role of
diet in relation to breast cancer, particularly the role of fat, is
inconclusive. Ecological analysis (Prentice and Sheppard, 1990),
pooled analysis of case-control studies (Howe et al, 1990), meta-
analysis ofcohort and case-control studies (Boyd et al, 1993), and
animal experimental evidence (Freedman et al, 1990) all suggest a
positive association between dietary fat intake and breast cancer
incidence. In contrast, cohort studies have shown null or weakly
positive associations. A recently published combined analysis of
cohort studies showed no relationship between fat intake and
breast cancer risk (Hunter et al, 1996). All observational epidemi-
ological studies are, however, likely to be affected by the limited
range of fat intake found within most populations and by error in
the measurement of intake (Goodwin and Boyd, 1987). The
present trial is designed to increase the range of dietary fat intake
within a group of participants at increased risk for breast cancer to
increase the probability of observing biological effects relevant to
breast cancer.
Observation of subjects now in the trial, as well as others yet to
be enrolled, is needed to determine ultimately the magnitude ofthe
long-term effect of dietary intervention on oestradiol levels and
whether this effect influences breast cancer incidence. Further
observation will also be needed to determine whether any
undesired health effects, such as osteoporosis, are associated with
the observed changes in oestradiol levels.
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APPENDIX I
Canadian Diet and Breast Cancer Study Group
Site Hamilton
Principal investigator Dr T Minuk (Henderson
General & OBSP)
Radiologist(s) Dr L Martin (St Joseph's Hospital)
Dr L Miller (Brantford General)
Dr B Shaw (St Mary's Hospital,
Kitchener)
Dr G Tarulli (Concession Street
X-Ray & Ultrasound)
Dr DA Wycoco (Grand River
Hospital, Kitchener)
Dietitian(s) K Featherstone
Support staff L Peters
Site London
Principal investigator Dr L Levin
Radiologist(s) Dr KW Mahon (Sarnia General
Hospital)
Dr L McCurdy (St Joseph's Health
Centre & London X-Ray Associates)
Dr W Papoff (St Thomas-Elgin
General Hospital)
Dr JD Schwanz (Ontario Breast
Screening Program)
Dr K Sparrow (Victoria Hospital)
Dr B Vinson (Woodstock General
Hospital)
Dietitian(s) M Boston
A Lenny
L White
Support staff J Shugar
Site Toronto - coordinating centre
Principal investigator Dr NF Boyd
Physicists Dr MJ Yaffe
J Byng
Statisticians Dr DL Tritchler
G. Lockwood
Coinvestigators Dr S Aitken (Ontario Breast
Screening Program)
Dr R Jong (Mount Sinai Hospital)
Dr J Koo (St Michael's Hospital)
Dr I Koven (Mount Sinai Hospital)
Dr L Lickley (Women's College
Hospital)
Dr L Mahoney (St. Michael's
Hospital)
Dr S Sidlofsky (Mount Sinai
Hospital)
Dr DL Tritchler (Ontario Cancer
Institute)
Dr MJ Yaffe (Sunnybrook Health
Sciences Centre)
Radiologist(s) Dr ND Greyson (St. Michael's
Hospital)
Dr E Fishell (Women's College
Hospital)
Dr R Jong (Mount Sinai Hospital)
Dr I Simor (Mount Sinai Hospital)
Dr N Wadden (The Toronto
Hospital)
Dr J Weinroth (Ontario Breast
Screening Program)
Dr B Wright (Women's College
Hospital)
Dietitian(s) D Acal
M Beaton
L Gougeon
C Greenberg
R Mazer
L Valleau
Research associate L Martin
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Data manager
Support staff
Site
Principal investigator(s)
Dietitian(s)
Support staff
V Kriukov
M Jorgensen
C McMaster
Vancouver
Dr T Greg Hislop
S Iwama
S Monkman
C Orphanidou
E Soon
N Vidas
T Labo
R Rogers
E Rousseau
C Treloar
Site
Principal investigator(s)
Radiologist(s):
Dietitian(s)
Support staff
Windsor
Dr B Heartwell
Dr JC MacDonald
Dr W Ramsewak (Metropolitan
Hospital and The Ontario Breast
Screening Program)
K Nohavicka
C Williams
S Cammalleri
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